MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study
Table 3
Correlation analysis between MYL5 and relate genes and markers of B cell, macrophages, TAM, monocyte, and T cell exhaustion in GEPIA2.
Description
Gene markers
BRCA
Cancer
Normal
Cor
Cor
B cell
CD20 (KRT20)
−0.14
0.051
0.59
CD19
−0.061
0.054
0.57
CD38
−0.29
−0.099
0.3
M1 Macrophage
NOS2
−0.15
0.23
COX (PTGS2)
−0.2
−0.17
0.075
M2 Macrophage
CD163
−0.21
−0.056
0.56
MS4A4A
−0.2
−0.16
0.1
VSIG4
−0.093
−0.12
0.22
TAM
CCL2
−0.18
−0.2
CD68
−0.22
−0.21
IL10
−0.19
−0.087
0.36
Monocyte
CD86
−0.22
−0.28
CD16 (FCGR3A)
−0.19
−0.22
T cell exhaustion
PD1 (PDCD1)
−0.089
0.024
0.8
PD-L1 (CD274)
−0.16
−0.36
CTLA4
−0.22
−0.043
0.66
BRCA: breast invasive carcinoma, TAM: tumor-associated macrophage, None: correlation without adjustment, and C or, R value of Spearman’s correlation. ,,, and .
